Adherence to lipid-lowering guidelines for secondary prevention and potential reduction in CVD events in Swedish primary care: a cross-sectional study

Of 37,120 pts, 18% reached target LDL-C ≤1.8 mmol/L and 32% were not on statin treatment. Based on individual risks, estimated number of CVD events in the study group over 5 years was 9209. If all patients achieved LDL-C ≤1.8 mmol/L, the number of events could be reduced by 18%.

SPS commentary:

The researchers also estimated if all pts without a statin or with less potent statin treatment were given atorvastatin 80 mg, an estimated reduction of CVD events by 14% could be expected.

BMJ Open